Solid-phase synthesis of 'head-to-side chain' cyclic tripeptides using allyl deprotection

Tetrahedron Letters

Volumn 38, Issue 7, 1997, Pages 1191-1194

  Flouzat, C ^a   Marguerite, F ^a   Croizet, F ^a   Percebois, M ^a   Monteil, A ^a   Combourieu, M ^a  

^a CERM Centre Europeen de Recherches Mauvernay   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPEPTIDE; ENDOTHELIN RECEPTOR ANTAGONIST; TRIPEPTIDE;

ARTICLE; CYCLIZATION; DRUG DESIGN; DRUG PURIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; METHODOLOGY; PEPTIDE SYNTHESIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0031575596     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(97)00061-0     Document Type: Article

References (27)

1. 4: tetrakistriphenylphosphine palladium(O), PyBOP: benzotriazol-1-yloxy-tris(pyrrolidino)phosphoniurn hexafluorophosphate; SPPS: solid-phase synthesis, TBTU: 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate, TFA: trifluoroacetic acid; TFE: trifluoroethanol.
2. 2) Yanagisawa, M., Kurihara, H., Kimura, S., Tornobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., Masaki, T, Nature, 1988; 332, 411-415.
3. 3) Ferro, C. J., Webb D. J., Drugs, 1996; 57, 1, 12-27.
4. 4) Sakurai, T., Yanagisawa, M., Masaki, T., Trends Pharmacol.Sci., 1992, 13, 103-108.
5. 5) a) Cody, W. L., Doherty, A. M., Biopolymers (Peptide Science), 1995, 37, 89-104.
6. b) Ishikawa, K. , Fukami, T. , Mase, T., Nagase, T., Hayama, T., Niiyama, K., Ihara, M., Saeki, T., Osaki, S., Nishikibe, M., Mino, N., Noguchi, K., Fukuroda, T., Yano, M., Eur. J. Med. Chem., 1995, 30 suppl(Is-688s), 371s-383s.
7. c) Cheng, X. M., Nikam, S. S., Doherty, A. M., Curent Med. Chem., 1994, 1, 271-312.
8. 6) a) Ishikawa, K., Fukami, T., Nagase, T., Fujita, K., Hayama, T., Niiyama, K., Mase, T., Ihara, M., Yano, M., J. Med. Chem. 1992, 35, 11, 2135-2142.
9. b) Moreland, S., Cardiovasc. Drug Reviews, 1994, 12, 1,48-69.
10. 7) a)Verheyden, P., Van Assche, I., Brichard, M. H., Demaude, T., Paye, I., Scarso, A., Van Bist, G., FEBS Lett., 1994, 344, 55-60.
11. b) Elliot, J. D., Lago, A. M., Cousins, R. D., Gao, A., Leber, J. D., Erhard, K. F., Nambi, P., Elshourbagy, N. A., Kumar, C., Lee, J. A., Bean, J. W., DeBrosse, C. W., Eggleston, D. S. Brooks, D. P., Feuerstein, G., Ruffolo, R. R. Weinstock, J. W., Gleason, J. G., Peishoff, C. E., Ohlstein, E. H., J. Med. Chem., 1994, 37, 1553-1557.
12. c) Hempel, J. C., Cordova de Sintjago, T., Guner, O., Hassan, M., Koerber, S. C., Vorpagel, E. R., Hagler, A. T; Eur. J. Med. Chem., 1995, 30 suppl(Is-688s), 392s-395s.
13. 8) Molecular Modelling: By varying the L and D configuration, eight different H-cyclo(Lys-Trp-Asp) peptides were built with Quanta/Charmm (Molecular Simulations). For each peptide, eight energy-minimized starting conformations were modelled by simply flipping the amide bonds above or below the average plane of the ring. Conformer generation was performed using high-temperature dynamic runs followed by energy minimisation and cluster analysis leading to 40 low-energy conformations. The above conformers were compared with the BQ-123 solution conformation (Atkinson, A. R., Pelton J. T., FEBS Lett., 1992, 296, 1, 1-6) using Chem-X (Chemical Design Ltd). For each conformation (out of 320), the following were fitted : average plane of the peptide rings, Trp and Asp side chains, and the CO and NH amide groups.
14. 9) Mazur, S., Jayaleshmy, P., J. Am. Chem. Soc., 1979, 101, 677-683.
15. 10) Stevens C. M., and Watanabe R., J. Am. Chem. Soc., 1950, 72, 725-727
16. 11) a) Friedrich-Bochnitschek, S., Waldmann, H., Kunz, H., J. Org. Chem., 1989, 54, 751-756.
17. b) Lyttle, M. H., Hudson, D., in "Peptide-Chemistry and Biology: Proceedings of the Twelfth American Peptide Symposium", (Smith J. A., and Rivier J. Ed.), Escom Leiden, 1992, 583-584. Loffet, A., Zhang H. X. , In: "Innovation and Perspectives in Solid Phase Synthesis: Peptides, Polypeptides and Oligonucleotides", (Epton R. Ed.), Intercept Andover, 1992, 77-82.
18. b) Lyttle, M. H., Hudson, D., in "Peptide-Chemistry and Biology: Proceedings of the Twelfth American Peptide Symposium", (Smith J. A., and Rivier J. Ed.), Escom Leiden, 1992, 583-584. Loffet, A., Zhang H. X. , In: "Innovation and Perspectives in Solid Phase Synthesis: Peptides, Polypeptides and Oligonucleotides", (Epton R. Ed.), Intercept Andover, 1992, 77-82.
19. 12) a) Alsina, J., Rabanal, F., Giralt, E., Albericio, F., Tetrahedron Lett., 1994, 35, 9633-9636.
20. b) Trzeciak, A., Bannwarth, W., Tetrahedron Lett., 1992, 33, 4557-4560. Kates, S. A., Solé, N. A., Johnson ,C. R., Tetrahedron Lett., 1993, 34, 1549-1552.
21. b) Trzeciak, A., Bannwarth, W., Tetrahedron Lett., 1992, 33, 4557-4560. Kates, S. A., Solé, N. A., Johnson ,C. R., Tetrahedron Lett., 1993, 34, 1549-1552.
22. 13) Kates, S. A., Daniels, S. B., Albericio, F., Anal. Biochem., 1993, 212, 303-310.
23. + Amino acid analysis: Lys, 0.73; Asp, 1.00; Trp, 0.94.
24. 15) Barlos, K., Chatzi, Olga, Gatos, D., Stavropoulos, G; Int. J. Peptide Protein Res., 1991, 37, 513-520.
25. 3 (5 eq) (cyclization time: 48 h at 0°C).
26. 17) Brady, S. F., Freidinger, R. M., Paleveda, W. J., Colton, C. D., Homnick, C. F., Whitter, W. L., Curley, P., Nutt, R. F., Veber, D. F., J. Org. Chem., 1987, 52, 764-769
27. 3CN in water) from 5% to 65% B.